Teladoc Health's (TDOC) Sell (D-) Rating Reaffirmed at Weiss Ratings

Key Points

• Teladoc Health's stock was reaffirmed with a "sell (D-)" rating by Weiss Ratings, indicating ongoing concerns about the company's performance.
• While Weiss Ratings maintains a bearish outlook, other analysts have given mixed ratings, with Evercore ISI raising its price target to $9.00 and Zacks upgrading it to a strong-buy.
• Teladoc Health reported a net loss of $0.19 EPS for the last quarter, beating expectations, but its revenue showed a 1.6% year-over-year decline.

Teladoc Health (NYSE:TDOC - Get Free Report)'s stock had its "sell (d-)" rating reiterated by stock analysts at Weiss Ratings in a research note issued on Friday,Weiss Ratings reports.

Several other analysts have also recently weighed in on the stock. Evercore ISI lifted their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an "in-line" rating in a research note on Wednesday, October 8th. Zacks Research upgraded shares of Teladoc Health from a "hold" rating to a "strong-buy" rating in a research note on Friday, October 10th. Mizuho began coverage on shares of Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price objective for the company. Finally, Citigroup lifted their price objective on shares of Teladoc Health from $9.50 to $10.50 and gave the stock a "neutral" rating in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $9.97.

Teladoc Health Stock Performance

NYSE TDOC opened at $9.49 on Friday. The firm has a 50-day moving average of $8.11 and a 200-day moving average of $7.67. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The stock has a market cap of $1.68 billion, a PE ratio of -7.97 and a beta of 1.90. Teladoc Health has a 52-week low of $6.35 and a 52-week high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. During the same quarter in the previous year, the company earned ($0.38) EPS. The business's revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, sell-side analysts anticipate that Teladoc Health will post -1.16 EPS for the current year.

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. Golden State Wealth Management LLC raised its position in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares in the last quarter. National Bank of Canada FI grew its holdings in shares of Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after purchasing an additional 1,581 shares during the last quarter. SVB Wealth LLC bought a new stake in shares of Teladoc Health during the 1st quarter valued at approximately $37,000. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Teladoc Health during the 1st quarter valued at approximately $50,000. Finally, Bayforest Capital Ltd bought a new stake in shares of Teladoc Health during the 3rd quarter valued at approximately $58,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.